Poor recruitment to lung cancer trials

BMJ 1997; 314 doi: https://doi.org/10.1136/bmj.314.7085.974a (Published 29 March 1997) Cite this as: BMJ 1997;314:974
  1. Richard T Pensona, Senior registrar,
  2. Robin M Rudda, Consultant physician
  1. a Department of Medical Oncology, St Bartholomew's Hospital, London EC1A 7BE

    Editor–The Sheffield Lymphoma Group's recent audit confirms that a “positive attitude” enables high rates of recruitment (45%) to clinical trials.1 It was frustrating to have no further information about the 7% of eligible patients who were considered for, but not entered on, studies. Why are one in seven patients not entered if less than 1% refuse, and did this ratio come closer to one in four in 1992 if, as is apparent, recruitment fell at a faster …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription